Hochschulschrift
Tumor growth inhibition by RGD peptide directed delivery of truncated tissue factor to the tumor vasculature
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Münster (Westfalen), Univ., 3004
- Schlagwort
-
Krebs
Onkologie
Iatrogene Krankheit
Therapie
Compliance
- Urheber
- URN
-
urn:nbn:de:hbz:6-67669447079
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Tumor growth inhibition by RGD peptide directed delivery of truncated tissue factor to the tumor vasculature
CXCR4-directed imaging in solid tumors
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
Verbesserung der Diagnose solider Karzinome durch das Tumor-penetrierende Peptid iRGD
Repurposing tamoxifen for tumor microenvironment priming and enhanced tumor‐targeted drug delivery
Monitoring and modulating drug delivery to tumors
Biomarker export induced by the tumor-penetrating iRGD peptide in hepatocellular carcinoma
Tumor vaccination : Chitosan nanoparticles as antigen vehicles to promote tumor-directed T cell responses
The tumor-penetrating iRGD improves therapy and diagnosis in preclinical hepatocellular carcinoma models
Targeted lipid-coated nanoparticles : delivery of tumor necrosis factor-functionalized particles to tumor cells
Directed evolution of arginine deiminase (ADI) for anti-tumor application
Polymeric nanoparticles for therapeutic drug delivery und tumor treatment
Tumor growth inhibition by RGD peptide directed delivery of truncated tissue factor to the tumor vasculature
CXCR4-directed imaging in solid tumors
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
Verbesserung der Diagnose solider Karzinome durch das Tumor-penetrierende Peptid iRGD
Repurposing tamoxifen for tumor microenvironment priming and enhanced tumor‐targeted drug delivery
Monitoring and modulating drug delivery to tumors
Biomarker export induced by the tumor-penetrating iRGD peptide in hepatocellular carcinoma
Tumor vaccination : Chitosan nanoparticles as antigen vehicles to promote tumor-directed T cell responses
The tumor-penetrating iRGD improves therapy and diagnosis in preclinical hepatocellular carcinoma models
Targeted lipid-coated nanoparticles : delivery of tumor necrosis factor-functionalized particles to tumor cells
Directed evolution of arginine deiminase (ADI) for anti-tumor application
Polymeric nanoparticles for therapeutic drug delivery und tumor treatment
Tumor growth inhibition by RGD peptide directed delivery of truncated tissue factor to the tumor vasculature
CXCR4-directed imaging in solid tumors
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
Verbesserung der Diagnose solider Karzinome durch das Tumor-penetrierende Peptid iRGD
Repurposing tamoxifen for tumor microenvironment priming and enhanced tumor‐targeted drug delivery
Monitoring and modulating drug delivery to tumors
Biomarker export induced by the tumor-penetrating iRGD peptide in hepatocellular carcinoma
Tumor vaccination : Chitosan nanoparticles as antigen vehicles to promote tumor-directed T cell responses
The tumor-penetrating iRGD improves therapy and diagnosis in preclinical hepatocellular carcinoma models
Targeted lipid-coated nanoparticles : delivery of tumor necrosis factor-functionalized particles to tumor cells
Directed evolution of arginine deiminase (ADI) for anti-tumor application